Taiko Pharmaceutical Co (TSE:4574) Total Liabilities : 円5,574 Mil (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Taiko Pharmaceutical Co Total Liabilities?

Taiko Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2024 was 円5,574 Mil.

Taiko Pharmaceutical Co's quarterly Total Liabilities increased from Sep. 2023 (円6,051.00 Mil) to Dec. 2023 (円6,482.00 Mil) but then declined from Dec. 2023 (円6,482.00 Mil) to Mar. 2024 (円5,574.00 Mil).

Taiko Pharmaceutical Co's annual Total Liabilities increased from Mar. 2020 (円6,099.80 Mil) to Dec. 2021 (円9,730.00 Mil) but then declined from Dec. 2021 (円9,730.00 Mil) to Dec. 2022 (円7,003.00 Mil).

Taiko Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Taiko Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiko Pharmaceutical Co Total Liabilities Chart

Taiko Pharmaceutical Co Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Dec21

Dec22

Total Liabilities

Get a 7-Day Free Trial

4,053.19

4,114.69

6,099.80

9,730.00

7,003.00

Taiko Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															6,549.00	6,460.00	6,051.00	6,482.00	5,574.00

Taiko Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Taiko Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2793	+	(2741	+	810
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	659)
	=	7,003

Total Liabilities	=	Total Assets (A: Dec. 2022 )	-	Total Equity (A: Dec. 2022 )
	=	15046	-	8043
	=	7,003

Taiko Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2500	+	(1627	+	812
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	635)
	=	5,574

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	12997	-	7423
	=	5,574

Taiko Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Taiko Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Taiko Pharmaceutical Co (TSE:4574) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taiko Pharmaceutical Co Ltd (TSE:4574) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 34 Third Street, No. 14, Uchihon Suita, Osaka, JPN, 564-0032

Website

http://www.seirogan.co.jp

Taiko Pharmaceutical Co Ltd operates in three segments, namely Pharmaceutical, Infection Control, and Others. The majority of its revenue comes from Infection Control, which is into manufacturing and sales of sanitation control products, including Cleverin, Cleverin LED, and Cleverin Generator LISPASS. The pharmaceutical segment is into the manufacturing and sales of OTC medicines and designated quasi-drugs. Other business includes manufacturing and sales of wood vinegar-based products.

Taiko Pharmaceutical Co (TSE:4574) Headlines

No Headlines